3 terminated, 1 completed. 1 Early Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Mafenide: new trials by email Literature Review of Mafenide trials Research Report on Mafenide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| Vashe Wound Therapy Study Vashe, Mafenide acetate - Burns | Not applicable | Completed | Valleywise Health | 23 | 2009-07-01 | 2012-09-14 |
| Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group Sulfamylon® For 5 % Topical Solution, Topical Antimicrobial/Antifungal Medications - Burns | Phase 4 | Terminated | Mylan Inc. | 220 | 2007-09-01 | 2022-09-29 |
| Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks Sulfamylon 5% and Silver Nitrate Soaks - Burn | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 98 | 1995-07-01 | 2023-06-22 |
Burns (3) · Osteomyelitis (1) · Wound Infection (1) · Wounds and Injuries (1)
Julio Ramirez (1) · Mylan Inc. (1) · The University of Texas Medical Branch, Galveston (1) · Valleywise Health (1)
United States (4)
David N Herndon, MD (1) · David Seligson, MD (1) · Eric Davis, MD (1) · Julio Ramirez, MD (1) · Kevin Foster, MD (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 4902833, PMID 8948280